News Center
The Project Accomplished on a Collaborative Basis by CHIATAI QINGCHUNBAO, Which is Affiliated to Shanghai Pharma, Wins the First Prize of the National Award for Science and Technology Progress 2014

    On January 27, 2015, CHIATAI QINGCHUNBAO, one of the subsidiaries of Shanghai Pharma, held press conferences in Hangzhou and Shanghai for communications with regard to the award-winning project “Innovative R&D and Industrialization of the Core Technology System of Secondary Development of the Chinese Patent Drugs”, which was accomplished by CHIATAI QINGCHUNBAO in collaboration with relevant universities and companies and Shanghai Pharma’s scientific and technological innovations in traditional Chinese medicine R&D.

    It is learnt from the recent national science and technology award conference that the project titled Innovative R&D and Industrialization of the Core Technology System of Secondary Development of the Chinese Patent Drugs, which was led by the Academician Zhang Boli and accomplished on a collaborative basis by Tianjin University of Traditional Chinese Medicine, Zhejiang University, China Academy of Chinese Medical Sciences, CHIATAI QINGCHUNBAO PHARMACEUTICAL CO., LTD. and Tianjin Pharmaceutical Holdings Ltd., won the first prize of the National Award for Science and Technology Progress. It is the only innovative result in the pharmaceutical industry that won the first prize of the National Award for Science and Technology Progress of the year.

The subject of concern
Produced By 大汉网络 大汉版通发布系统